{
  "symbol": "PEP",
  "year": 2023,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1575,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.135
  },
  "top_positive": [
    {
      "sent": "20 Table of Contents Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows: 12 Weeks Ended 9/9/2023 9/3/2022 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange $ \u2014 $ ( 7 ) $ ( 7 ) $ \u2014 $ ( 60 ) $ ( 60 ) Commodity ( 9 ) ( 65 ) ( 74 ) ( 2 ) 55 53 Total $ ( 9 ) $ ( 72 ) $ ( 81 ) $ ( 2 ) $ ( 5 ) $ ( 7 ) 36 Weeks Ended 9/9/2023 9/3/2022 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange $ ( 1 ) $ 32 $ 31 $ ( 3 ) $ ( 52 ) $ ( 55 ) Commodity 27 ( 12 ) 15 ( 136 ) ( 158 ) ( 294 ) Total $ 26 $ 20 $ 46 $ ( 139 ) $ ( 210 ) $ ( 349 ) Note 10 - Net Income Attributable to PepsiCo per Common Share The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 12 Weeks Ended 9/9/2023 9/3/2022 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 2.25 $ 1.96 Net income available for PepsiCo common shareholders $ 3,092 1,376 $ 2,702 1,380 Dilutive securities: Stock options, RSUs, PSUs and other (b) \u2014 7 \u2014 7 Diluted $ 3,092 1,383 $ 2,702 1,387 Diluted net income attributable to PepsiCo per common share $ 2.24 $ 1.95 36 Weeks Ended 9/9/2023 9/3/2022 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 5.64 $ 6.07 Net income available for PepsiCo common shareholders $ 7,772 1,377 $ 8,392 1,382 Dilutive securities: Stock options, RSUs, PSUs and other (b) \u2014 7 \u2014 7 Diluted $ 7,772 1,384 $ 8,392 1,389 Diluted net income attributable to PepsiCo per common share $ 5.62 $ 6.04 (a) Weighted-average common shares outstanding (in millions).",
      "score": 0.979
    },
    {
      "sent": "and Subsidiaries (in millions except per share amounts, unaudited) 12 Weeks Ended 36 Weeks Ended 9/9/2023 9/3/2022 9/9/2023 9/3/2022 Net Revenue $ 23,453 $ 21,971 $ 63,621 $ 58,396 Cost of sales 10,675 10,308 28,784 27,156 Gross profit 12,778 11,663 34,837 31,240 Selling, general and administrative expenses 8,757 8,295 24,528 22,262 Gain associated with the Juice Transaction (a) \u2014 14 \u2014 ( 3,321 ) Impairment of intangible assets (see Notes 1 and 4) 6 1 6 1,602 Operating Profit 4,015 3,353 10,303 10,697 Other pension and retiree medical benefits income 62 36 183 168 Net interest expense and other ( 201 ) ( 190 ) ( 602 ) ( 666 ) Income before income taxes 3,876 3,199 9,884 10,199 Provision for income taxes 760 475 2,053 1,756 Net income 3,116 2,724 7,831 8,443 Less: Net income attributable to noncontrolling interests 24 22 59 51 Net Income Attributable to PepsiCo $ 3,092 $ 2,702 $ 7,772 $ 8,392 Net Income Attributable to PepsiCo per Common Share Basic $ 2.25 $ 1.96 $ 5.64 $ 6.07 Diluted $ 2.24 $ 1.95 $ 5.62 $ 6.04 Weighted-average common shares outstanding Basic 1,376 1,380 1,377 1,382 Diluted 1,383 1,387 1,384 1,389 (a) In the 36 weeks ended September 3, 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for $ 3.5 billion in cash and a 39 % noncontrolling interest in a joint venture, Tropicana Brands Group (TBG), operating across North America and Europe (Juice Transaction).",
      "score": 0.9776
    },
    {
      "sent": "Fair Value Measurements The fair values of our financial assets and liabilities as of September\u00a09, 2023 and December\u00a031, 2022 are categorized as follows: 9/9/2023 12/31/2022 Fair Value Hierarchy Levels (a) Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale debt securities (b) 2 $ 558 $ \u2014 $ 660 $ \u2014 Index funds (c) 1 $ 265 $ \u2014 $ 257 $ \u2014 Prepaid forward contracts (d) 2 $ 14 $ \u2014 $ 14 $ \u2014 Deferred compensation (e) 2 $ \u2014 $ 439 $ \u2014 $ 434 Derivatives designated as cash flow hedging instruments: Foreign exchange (f) 2 $ 11 $ 37 $ 24 $ 22 Interest rate (f) 2 \u2014 161 \u2014 164 Commodity (g) 2 \u2014 49 2 60 $ 11 $ 247 $ 26 $ 246 Derivatives not designated as hedging instruments: Foreign exchange (f) 2 $ 18 $ 18 $ 21 $ 21 Commodity (g) 2 10 17 11 51 $ 28 $ 35 $ 32 $ 72 Total derivatives at fair value (h) $ 39 $ 282 $ 58 $ 318 Total $ 876 $ 721 $ 989 $ 752 (a) Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets) and Level 2 (significant other observable inputs) in both years.",
      "score": 0.9747
    }
  ],
  "top_negative": [
    {
      "sent": "and Subsidiaries (in millions, unaudited) 36 Weeks Ended 9/9/2023 9/3/2022 Financing Activities Proceeds from issuances of long-term debt $ 2,986 $ 3,377 Payments of long-term debt ( 2,253 ) ( 1,653 ) Debt redemptions \u2014 ( 1,550 ) Short-term borrowings, by original maturity: More than three months - proceeds 4,688 1,947 More than three months - payments ( 1,037 ) ( 1,932 ) Three months or less, net 1,395 ( 45 ) Cash dividends paid ( 4,941 ) ( 4,586 ) Share repurchases - common ( 751 ) ( 1,156 ) Proceeds from exercises of stock options 100 113 Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted ( 135 ) ( 97 ) Other financing ( 18 ) ( 25 ) Net Cash Provided by/(Used for) Financing Activities 34 ( 5,607 ) Effect of exchange rate changes on cash and cash equivalents and restricted cash ( 254 ) ( 197 ) Net Increase in Cash and Cash Equivalents and Restricted Cash 5,031 811 Cash and Cash Equivalents and Restricted Cash, Beginning of Year 5,100 5,707 Cash and Cash Equivalents and Restricted Cash, End of Period $ 10,131 $ 6,518 Supplemental Non-Cash Activity Right-of-use assets obtained in exchange for lease obligations $ 705 $ 560 Debt discharged via legal defeasance $ 94 $ \u2014 See accompanying notes to the condensed consolidated financial statements.",
      "score": -0.9186
    },
    {
      "sent": "Risks Associated with the Deadly Conflict in Ukraine In addition to the risks associated with international operations discussed above, we continue to face risks associated with the deadly conflict in Ukraine.",
      "score": -0.836
    },
    {
      "sent": "Risks Associated with the Deadly Conflict in Ukraine In addition to the risks associated with international operations discussed above, we continue to face risks associated with the deadly conflict in Ukraine.",
      "score": -0.836
    }
  ],
  "forward_snippets": [
    "A summary of pre-tax charges related to the impairment of intangible assets is as follows: 12 Weeks Ended 36 Weeks Ended 9/9/2023 9/3/2022 9/9/2023 9/3/2022 Russia-Ukraine conflict impairment charges $ \u2014 $ \u2014 $ \u2014 $ 1,198 Brand portfolio impairment charges \u2014 1 \u2014 404 Other impairment charges 6 \u2014 6 \u2014 Total $ 6 $ 1 $ 6 $ 1,602 Note 2 - Recently Issued Accounting Pronouncements Adopted In September 2022, the Financial Accounting Standards Board issued guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows.",
    "The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary.",
    "We adopted the guidance in the first quarter of 2023, except for the rollforward, which is effective in fiscal year 2024 with early adoption permitted.",
    "We currently plan to adopt the rollforward guidance when effective.",
    "See Note 13 for disclosures currently required under this guidance."
  ],
  "curated_text": "Symbol: PEP. Year: 2023. Period: Q1. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 20 Table of Contents Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows: 12 Weeks Ended 9/9/2023 9/3/2022 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange $ \u2014 $ ( 7 ) $ ( 7 ) $ \u2014 $ ( 60 ) $ ( 60 ) Commodity ( 9 ) ( 65 ) ( 74 ) ( 2 ) 55 53 Total $ ( 9 ) $ ( 72 ) $ ( 81 ) $ ( 2 ) $ ( 5 ) $ ( 7 ) 36 Weeks Ended 9/9/2023 9/3/2022 Cost of sales Selling, general and administrative expenses Total Cost of sales Selling, general and administrative expenses Total Foreign exchange $ ( 1 ) $ 32 $ 31 $ ( 3 ) $ ( 52 ) $ ( 55 ) Commodity 27 ( 12 ) 15 ( 136 ) ( 158 ) ( 294 ) Total $ 26 $ 20 $ 46 $ ( 139 ) $ ( 210 ) $ ( 349 ) Note 10 - Net Income Attributable to PepsiCo per Common Share The computations of basic and diluted net income attributable to PepsiCo per common share are as follows: 12 Weeks Ended 9/9/2023 9/3/2022 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 2.25 $ 1.96 Net income available for PepsiCo common shareholders $ 3,092 1,376 $ 2,702 1,380 Dilutive securities: Stock options, RSUs, PSUs and other (b) \u2014 7 \u2014 7 Diluted $ 3,092 1,383 $ 2,702 1,387 Diluted net income attributable to PepsiCo per common share $ 2.24 $ 1.95 36 Weeks Ended 9/9/2023 9/3/2022 Income Shares (a) Income Shares (a) Basic net income attributable to PepsiCo per common share $ 5.64 $ 6.07 Net income available for PepsiCo common shareholders $ 7,772 1,377 $ 8,392 1,382 Dilutive securities: Stock options, RSUs, PSUs and other (b) \u2014 7 \u2014 7 Diluted $ 7,772 1,384 $ 8,392 1,389 Diluted net income attributable to PepsiCo per common share $ 5.62 $ 6.04 (a) Weighted-average common shares outstanding (in millions). and Subsidiaries (in millions except per share amounts, unaudited) 12 Weeks Ended 36 Weeks Ended 9/9/2023 9/3/2022 9/9/2023 9/3/2022 Net Revenue $ 23,453 $ 21,971 $ 63,621 $ 58,396 Cost of sales 10,675 10,308 28,784 27,156 Gross profit 12,778 11,663 34,837 31,240 Selling, general and administrative expenses 8,757 8,295 24,528 22,262 Gain associated with the Juice Transaction (a) \u2014 14 \u2014 ( 3,321 ) Impairment of intangible assets (see Notes 1 and 4) 6 1 6 1,602 Operating Profit 4,015 3,353 10,303 10,697 Other pension and retiree medical benefits income 62 36 183 168 Net interest expense and other ( 201 ) ( 190 ) ( 602 ) ( 666 ) Income before income taxes 3,876 3,199 9,884 10,199 Provision for income taxes 760 475 2,053 1,756 Net income 3,116 2,724 7,831 8,443 Less: Net income attributable to noncontrolling interests 24 22 59 51 Net Income Attributable to PepsiCo $ 3,092 $ 2,702 $ 7,772 $ 8,392 Net Income Attributable to PepsiCo per Common Share Basic $ 2.25 $ 1.96 $ 5.64 $ 6.07 Diluted $ 2.24 $ 1.95 $ 5.62 $ 6.04 Weighted-average common shares outstanding Basic 1,376 1,380 1,377 1,382 Diluted 1,383 1,387 1,384 1,389 (a) In the 36 weeks ended September 3, 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for $ 3.5 billion in cash and a 39 % noncontrolling interest in a joint venture, Tropicana Brands Group (TBG), operating across North America and Europe (Juice Transaction). Fair Value Measurements The fair values of our financial assets and liabilities as of September\u00a09, 2023 and December\u00a031, 2022 are categorized as follows: 9/9/2023 12/31/2022 Fair Value Hierarchy Levels (a) Assets (a) Liabilities (a) Assets (a) Liabilities (a) Available-for-sale debt securities (b) 2 $ 558 $ \u2014 $ 660 $ \u2014 Index funds (c) 1 $ 265 $ \u2014 $ 257 $ \u2014 Prepaid forward contracts (d) 2 $ 14 $ \u2014 $ 14 $ \u2014 Deferred compensation (e) 2 $ \u2014 $ 439 $ \u2014 $ 434 Derivatives designated as cash flow hedging instruments: Foreign exchange (f) 2 $ 11 $ 37 $ 24 $ 22 Interest rate (f) 2 \u2014 161 \u2014 164 Commodity (g) 2 \u2014 49 2 60 $ 11 $ 247 $ 26 $ 246 Derivatives not designated as hedging instruments: Foreign exchange (f) 2 $ 18 $ 18 $ 21 $ 21 Commodity (g) 2 10 17 11 51 $ 28 $ 35 $ 32 $ 72 Total derivatives at fair value (h) $ 39 $ 282 $ 58 $ 318 Total $ 876 $ 721 $ 989 $ 752 (a) Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets) and Level 2 (significant other observable inputs) in both years. Top negative sentences: and Subsidiaries (in millions, unaudited) 36 Weeks Ended 9/9/2023 9/3/2022 Financing Activities Proceeds from issuances of long-term debt $ 2,986 $ 3,377 Payments of long-term debt ( 2,253 ) ( 1,653 ) Debt redemptions \u2014 ( 1,550 ) Short-term borrowings, by original maturity: More than three months - proceeds 4,688 1,947 More than three months - payments ( 1,037 ) ( 1,932 ) Three months or less, net 1,395 ( 45 ) Cash dividends paid ( 4,941 ) ( 4,586 ) Share repurchases - common ( 751 ) ( 1,156 ) Proceeds from exercises of stock options 100 113 Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted ( 135 ) ( 97 ) Other financing ( 18 ) ( 25 ) Net Cash Provided by/(Used for) Financing Activities 34 ( 5,607 ) Effect of exchange rate changes on cash and cash equivalents and restricted cash ( 254 ) ( 197 ) Net Increase in Cash and Cash Equivalents and Restricted Cash 5,031 811 Cash and Cash Equivalents and Restricted Cash, Beginning of Year 5,100 5,707 Cash and Cash Equivalents and Restricted Cash, End of Period $ 10,131 $ 6,518 Supplemental Non-Cash Activity Right-of-use assets obtained in exchange for lease obligations $ 705 $ 560 Debt discharged via legal defeasance $ 94 $ \u2014 See accompanying notes to the condensed consolidated financial statements. Risks Associated with the Deadly Conflict in Ukraine In addition to the risks associated with international operations discussed above, we continue to face risks associated with the deadly conflict in Ukraine. Risks Associated with the Deadly Conflict in Ukraine In addition to the risks associated with international operations discussed above, we continue to face risks associated with the deadly conflict in Ukraine. Forward-looking snippets: A summary of pre-tax charges related to the impairment of intangible assets is as follows: 12 Weeks Ended 36 Weeks Ended 9/9/2023 9/3/2022 9/9/2023 9/3/2022 Russia-Ukraine conflict impairment charges $ \u2014 $ \u2014 $ \u2014 $ 1,198 Brand portfolio impairment charges \u2014 1 \u2014 404 Other impairment charges 6 \u2014 6 \u2014 Total $ 6 $ 1 $ 6 $ 1,602 Note 2 - Recently Issued Accounting Pronouncements Adopted In September 2022, the Financial Accounting Standards Board issued guidance to enhance the transparency of supplier finance programs to allow financial statement users to understand the effect on working capital, liquidity and cash flows. The new guidance requires disclosure of key terms of the program, including a description of the payment terms, payment timing and assets pledged as security or other forms of guarantees provided to the finance provider or intermediary. We adopted the guidance in the first quarter of 2023, except for the rollforward, which is effective in fiscal year 2024 with early adoption permitted. We currently plan to adopt the rollforward guidance when effective. See Note 13 for disclosures currently required under this guidance."
}